North America Accounted for Largest Share in the Global Sleeping Aids Market, 2022

The global sleeping aids market is increasing, due to growing geriatric population and increasing awareness about sleep disorders by various organizations. Older people are more prone to sleep disorders, such as obstructive sleep apnea and insomnia. In addition, the lifestyle changes are leading to sleep disorder, due to the increased usage of caffeine, tobacco and alcohol. This has generated the demand for sleeping aids products. The long working hours and hectic work environment further hampers the quality of sleep, which is leading to an increased consumption of OTC drugs, thus encouraging the growth of the global sleeping aids market.

Access Full Report at: https://www.psmarketresearch.com/market-analysis/sleeping-aids-market

Among the various sleep disorders, the sleep apnea market segment is expected to witness the fastest growth in the global market during the forecast period. Among the various sleeping aids products, the mattress and pillows segment had the largest market size in the global market during 2015; however the sleep apnea devices segment is expected to witness fastest growth, at 6.9% CAGR during the period 2016 – 2022.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/sleeping-aids-market/report-sample

The key companies operating in the global sleeping aids market include Sanofi, Merck & Co., Pfizer Inc., Koninklijke Philips N.V, GlaxoSmithKline PLC, SleepMed Inc., Cadwell Laboratories Inc., Drive Medical Ltd., Natus Medical Incorporated, Takeda Pharmaceutical Company Limited, Compumedics Limited, CareFusion Corporation, and Teva Pharmaceutical Industries Ltd.

%d bloggers like this: